All In MedTech

FDA Clearance Tracker · P150048-S047

MITRIS RESILIA Mitral Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 16, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 16, 2022

Approved

Time to decision

590 days

Received Aug 3, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150048-S047
Device name
MITRIS RESILIA Mitral Valve
Applicant location
Irvine, CA
Received
Aug 3, 2020
Decided
Mar 16, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150048

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

Approval for material and design modifications related to the wireform, sewing ring, valve holder and valve handle

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.